Full interview with Eli Lilly CEO David Ricks on emergency use authorization of Covid treatment

The U.S. Food and Drug Administration on Monday authorized emergency use of Eli Lilly’s experimental Covid-19 antibody treatment for non-hospitalized patients older than 65 or who have certain chronic medical conditions. Eli Lilly CEO David Ricks joins "Squawk Box" to discuss the hopes for the treatment, how the drug is administered, plans to meet the global demand for the treatment and more.